◆ Market Data --:--
⛽ Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

10-Q Filing

IMMIX BIOPHARMA, INC. CIK: 1873835 Q2 2024
Company All Filings
Filing Information
Form Type 10-Q
Accession Number 0001493152-24-031358
Period End Date 20240630
Filing Date 20240812
Fiscal Year 2024
Fiscal Period Q2
XBRL Instance form10-q_htm.xml
Filing Contents

This filing contains the following financial statements:

Balance Sheet 144 Income Statement 164 Cash Flow Statement 122 Stockholders Equity 80
Balance Sheet 144 line items
Line Item Tag Value Unit Period
Preferred stock, par value PreferredStockParOrStatedValuePerShare $0.00 USD Point-in-time
Preferred stock, par value PreferredStockParOrStatedValuePerShare $0.00 USD Point-in-time
Preferred stock, par value PreferredStockParOrStatedValuePerShare $0.00 USD Point-in-time
Preferred stock, par value PreferredStockParOrStatedValuePerShare $0.00 USD Point-in-time
Preferred stock, shares authorized PreferredStockSharesAuthorized 10.00M shares Point-in-time
Preferred stock, shares authorized PreferredStockSharesAuthorized 10.00M shares Point-in-time
Preferred stock, shares authorized PreferredStockSharesAuthorized 10.00M shares Point-in-time
Preferred stock, shares authorized PreferredStockSharesAuthorized 10.00M shares Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $17.51M USD Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $17.51M USD Point-in-time
Preferred stock, shares issued PreferredStockSharesIssued 0.00 shares Point-in-time
Preferred stock, shares issued PreferredStockSharesIssued 0.00 shares Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $23.98M USD Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $23.98M USD Point-in-time
Preferred stock, shares issued PreferredStockSharesIssued 0.00 shares Point-in-time
Preferred stock, shares issued PreferredStockSharesIssued 0.00 shares Point-in-time
Preferred stock, shares outstanding PreferredStockSharesOutstanding 0.00 shares Point-in-time
Preferred stock, shares outstanding PreferredStockSharesOutstanding 0.00 shares Point-in-time
Preferred stock, shares outstanding PreferredStockSharesOutstanding 0.00 shares Point-in-time
Preferred stock, shares outstanding PreferredStockSharesOutstanding 0.00 shares Point-in-time
Tax receivable IncomeTaxReceivable $1.17M USD Point-in-time
Tax receivable IncomeTaxReceivable $1.17M USD Point-in-time
Tax receivable IncomeTaxReceivable $1.98M USD Point-in-time
Tax receivable IncomeTaxReceivable $1.98M USD Point-in-time
Common stock par value CommonStockParOrStatedValuePerShare $0.00 USD Point-in-time
Common stock par value CommonStockParOrStatedValuePerShare $0.00 USD Point-in-time
Common stock par value CommonStockParOrStatedValuePerShare $0.00 USD Point-in-time
Common stock par value CommonStockParOrStatedValuePerShare $0.00 USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $1.38M USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $1.38M USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $1.11M USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $1.11M USD Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 200.00M shares Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 200.00M shares Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 200.00M shares Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 200.00M shares Point-in-time
Total current assets AssetsCurrent $19.79M USD Point-in-time
Total current assets AssetsCurrent $19.79M USD Point-in-time
Total current assets AssetsCurrent $27.33M USD Point-in-time
Total current assets AssetsCurrent $27.33M USD Point-in-time
Common stock, shares issued CommonStockSharesIssued 19.99M shares Point-in-time
Common stock, shares issued CommonStockSharesIssued 19.99M shares Point-in-time
Other assets OtherAssetsNoncurrent $20.42K USD Point-in-time
Other assets OtherAssetsNoncurrent $20.42K USD Point-in-time
Common stock, shares issued CommonStockSharesIssued 27.50M shares Point-in-time
Common stock, shares issued CommonStockSharesIssued 27.50M shares Point-in-time
Other assets OtherAssetsNoncurrent - USD Point-in-time
Other assets OtherAssetsNoncurrent - USD Point-in-time
Deferred offering cost DeferredCosts $87.23K USD Point-in-time
Deferred offering cost DeferredCosts $87.23K USD Point-in-time
Common stock, shares outstanding CommonStockSharesOutstanding 27.43M shares Point-in-time
Common stock, shares outstanding CommonStockSharesOutstanding 27.43M shares Point-in-time
Common stock, shares outstanding CommonStockSharesOutstanding 19.92M shares Point-in-time
Common stock, shares outstanding CommonStockSharesOutstanding 19.92M shares Point-in-time
Deferred offering cost DeferredCosts - USD Point-in-time
Deferred offering cost DeferredCosts - USD Point-in-time
Treasury stock, shares TreasuryStockCommonShares 72,363.00 shares Point-in-time
Treasury stock, shares TreasuryStockCommonShares 72,363.00 shares Point-in-time
Right-of-use asset, net OperatingLeaseRightOfUseAsset $1.03M USD Point-in-time
Right-of-use asset, net OperatingLeaseRightOfUseAsset $1.03M USD Point-in-time
Treasury stock, shares TreasuryStockCommonShares 72,363.00 shares Point-in-time
Treasury stock, shares TreasuryStockCommonShares 72,363.00 shares Point-in-time
Right-of-use asset, net OperatingLeaseRightOfUseAsset - USD Point-in-time
Right-of-use asset, net OperatingLeaseRightOfUseAsset - USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $50.18K USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $50.18K USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $454.03K USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $454.03K USD Point-in-time
Total assets Assets $28.84M USD Point-in-time
Total assets Assets $28.84M USD Point-in-time
Total assets Assets $19.93M USD Point-in-time
Total assets Assets $19.93M USD Point-in-time
Accounts payable and accrued expenses AccountsPayableAndAccruedLiabilitiesCurrent $3.85M USD Point-in-time
Accounts payable and accrued expenses AccountsPayableAndAccruedLiabilitiesCurrent $3.85M USD Point-in-time
Accounts payable and accrued expenses AccountsPayableAndAccruedLiabilitiesCurrent $3.72M USD Point-in-time
Accounts payable and accrued expenses AccountsPayableAndAccruedLiabilitiesCurrent $3.72M USD Point-in-time
Operating lease liability - current OperatingLeaseLiabilityCurrent - USD Point-in-time
Operating lease liability - current OperatingLeaseLiabilityCurrent - USD Point-in-time
Operating lease liability - current OperatingLeaseLiabilityCurrent $48.36K USD Point-in-time
Operating lease liability - current OperatingLeaseLiabilityCurrent $48.36K USD Point-in-time
Total current liabilities LiabilitiesCurrent $3.90M USD Point-in-time
Total current liabilities LiabilitiesCurrent $3.90M USD Point-in-time
Total current liabilities LiabilitiesCurrent $3.72M USD Point-in-time
Total current liabilities LiabilitiesCurrent $3.72M USD Point-in-time
Operating lease liability long term OperatingLeaseLiabilityNoncurrent - USD Point-in-time
Operating lease liability long term OperatingLeaseLiabilityNoncurrent - USD Point-in-time
Operating lease liability long term OperatingLeaseLiabilityNoncurrent $1.04M USD Point-in-time
Operating lease liability long term OperatingLeaseLiabilityNoncurrent $1.04M USD Point-in-time
Total liabilities Liabilities $4.94M USD Point-in-time
Total liabilities Liabilities $4.94M USD Point-in-time
Total liabilities Liabilities $3.72M USD Point-in-time
Total liabilities Liabilities $3.72M USD Point-in-time
Commitments and contingencies CommitmentsAndContingencies - USD Point-in-time
Commitments and contingencies CommitmentsAndContingencies - USD Point-in-time
Commitments and contingencies CommitmentsAndContingencies - USD Point-in-time
Commitments and contingencies CommitmentsAndContingencies - USD Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding PreferredStockValue - USD Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding PreferredStockValue - USD Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding PreferredStockValue - USD Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding PreferredStockValue - USD Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,501,560 shares issued and 27,429,197 shares outstanding at June 30, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023 CommonStockValue $2.75K USD Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,501,560 shares issued and 27,429,197 shares outstanding at June 30, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023 CommonStockValue $2.75K USD Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,501,560 shares issued and 27,429,197 shares outstanding at June 30, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023 CommonStockValue $2.00K USD Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 27,501,560 shares issued and 27,429,197 shares outstanding at June 30, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023 CommonStockValue $2.00K USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $86.93M USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $86.93M USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $69.78M USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $69.78M USD Point-in-time
Accumulated other comprehensive income AccumulatedOtherComprehensiveIncomeLossNetOfTax $134.67K USD Point-in-time
Accumulated other comprehensive income AccumulatedOtherComprehensiveIncomeLossNetOfTax $134.67K USD Point-in-time
Accumulated other comprehensive income AccumulatedOtherComprehensiveIncomeLossNetOfTax $116.97K USD Point-in-time
Accumulated other comprehensive income AccumulatedOtherComprehensiveIncomeLossNetOfTax $116.97K USD Point-in-time
Accumulated deficit RetainedEarningsAccumulatedDeficit $-53.41M USD Point-in-time
Accumulated deficit RetainedEarningsAccumulatedDeficit $-53.41M USD Point-in-time
Accumulated deficit RetainedEarningsAccumulatedDeficit $-63.06M USD Point-in-time
Accumulated deficit RetainedEarningsAccumulatedDeficit $-63.06M USD Point-in-time
Treasury stock at cost, 72,363 shares as of June 30, 2024 and December 31, 2023 TreasuryStockValue $99.96K USD Point-in-time
Treasury stock at cost, 72,363 shares as of June 30, 2024 and December 31, 2023 TreasuryStockValue $99.96K USD Point-in-time
Treasury stock at cost, 72,363 shares as of June 30, 2024 and December 31, 2023 TreasuryStockValue $99.96K USD Point-in-time
Treasury stock at cost, 72,363 shares as of June 30, 2024 and December 31, 2023 TreasuryStockValue $99.96K USD Point-in-time
Total Immix Biopharma, Inc. stockholders equity StockholdersEquity $23.89M USD Point-in-time
Total Immix Biopharma, Inc. stockholders equity StockholdersEquity $23.89M USD Point-in-time
Total Immix Biopharma, Inc. stockholders equity StockholdersEquity $16.41M USD Point-in-time
Total Immix Biopharma, Inc. stockholders equity StockholdersEquity $16.41M USD Point-in-time
Non-controlling interests MinorityInterest $-201.74K USD Point-in-time
Non-controlling interests MinorityInterest $-201.74K USD Point-in-time
Non-controlling interests MinorityInterest - USD Point-in-time
Non-controlling interests MinorityInterest - USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time
Total stockholders equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time
Total liabilities and stockholders equity LiabilitiesAndStockholdersEquity $28.84M USD Point-in-time
Total liabilities and stockholders equity LiabilitiesAndStockholdersEquity $28.84M USD Point-in-time
Total liabilities and stockholders equity LiabilitiesAndStockholdersEquity $19.93M USD Point-in-time
Total liabilities and stockholders equity LiabilitiesAndStockholdersEquity $19.93M USD Point-in-time
Income Statement 164 line items
Line Item Tag Value Unit Period
General and administrative expenses GeneralAndAdministrativeExpense $2.71M USD 2 Qtrs
General and administrative expenses GeneralAndAdministrativeExpense $2.71M USD 2 Qtrs
General and administrative expenses GeneralAndAdministrativeExpense $4.82M USD 2 Qtrs
General and administrative expenses GeneralAndAdministrativeExpense $4.82M USD 2 Qtrs
General and administrative expenses GeneralAndAdministrativeExpense $2.48M USD 1 Quarter
General and administrative expenses GeneralAndAdministrativeExpense $2.48M USD 1 Quarter
General and administrative expenses GeneralAndAdministrativeExpense $1.51M USD 1 Quarter
General and administrative expenses GeneralAndAdministrativeExpense $1.51M USD 1 Quarter
Research and development ResearchAndDevelopmentExpense $5.47M USD 2 Qtrs
Research and development ResearchAndDevelopmentExpense $5.47M USD 2 Qtrs
Research and development ResearchAndDevelopmentExpense $2.21M USD 1 Quarter
Research and development ResearchAndDevelopmentExpense $2.21M USD 1 Quarter
Research and development ResearchAndDevelopmentExpense $2.22M USD 1 Quarter
Research and development ResearchAndDevelopmentExpense $2.22M USD 1 Quarter
Research and development ResearchAndDevelopmentExpense $3.53M USD 2 Qtrs
Research and development ResearchAndDevelopmentExpense $3.53M USD 2 Qtrs
Total operating expenses OperatingExpenses $3.72M USD 1 Quarter
Total operating expenses OperatingExpenses $3.72M USD 1 Quarter
Total operating expenses OperatingExpenses $6.24M USD 2 Qtrs
Total operating expenses OperatingExpenses $6.24M USD 2 Qtrs
Total operating expenses OperatingExpenses $4.70M USD 1 Quarter
Total operating expenses OperatingExpenses $4.70M USD 1 Quarter
Total operating expenses OperatingExpenses $10.29M USD 2 Qtrs
Total operating expenses OperatingExpenses $10.29M USD 2 Qtrs
Loss from operations OperatingIncomeLoss $-4.70M USD 1 Quarter
Loss from operations OperatingIncomeLoss $-4.70M USD 1 Quarter
Loss from operations OperatingIncomeLoss $-3.72M USD 1 Quarter
Loss from operations OperatingIncomeLoss $-3.72M USD 1 Quarter
Loss from operations OperatingIncomeLoss $-10.29M USD 2 Qtrs
Loss from operations OperatingIncomeLoss $-10.29M USD 2 Qtrs
Loss from operations OperatingIncomeLoss $-6.24M USD 2 Qtrs
Loss from operations OperatingIncomeLoss $-6.24M USD 2 Qtrs
Interest income InvestmentIncomeInterest $306.92K USD 1 Quarter
Interest income InvestmentIncomeInterest $306.92K USD 1 Quarter
Interest income InvestmentIncomeInterest $156.74K USD 2 Qtrs
Interest income InvestmentIncomeInterest $156.74K USD 2 Qtrs
Interest income InvestmentIncomeInterest $574.82K USD 2 Qtrs
Interest income InvestmentIncomeInterest $574.82K USD 2 Qtrs
Interest income InvestmentIncomeInterest $128.85K USD 1 Quarter
Interest income InvestmentIncomeInterest $128.85K USD 1 Quarter
Total other expense, net NonoperatingIncomeExpense $156.74K USD 2 Qtrs
Total other expense, net NonoperatingIncomeExpense $156.74K USD 2 Qtrs
Total other expense, net NonoperatingIncomeExpense $574.82K USD 2 Qtrs
Total other expense, net NonoperatingIncomeExpense $574.82K USD 2 Qtrs
Total other expense, net NonoperatingIncomeExpense $306.92K USD 1 Quarter
Total other expense, net NonoperatingIncomeExpense $306.92K USD 1 Quarter
Total other expense, net NonoperatingIncomeExpense $128.85K USD 1 Quarter
Total other expense, net NonoperatingIncomeExpense $128.85K USD 1 Quarter
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-6.08M USD 2 Qtrs
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-6.08M USD 2 Qtrs
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-9.72M USD 2 Qtrs
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-9.72M USD 2 Qtrs
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-4.40M USD 1 Quarter
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-4.40M USD 1 Quarter
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-3.59M USD 1 Quarter
Loss before provision for income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-3.59M USD 1 Quarter
Provision for income taxes IncomeTaxExpenseBenefit $19.11K USD 2 Qtrs
Provision for income taxes IncomeTaxExpenseBenefit $19.11K USD 2 Qtrs
Provision for income taxes IncomeTaxExpenseBenefit $6.35K USD 1 Quarter
Provision for income taxes IncomeTaxExpenseBenefit $6.35K USD 1 Quarter
Provision for income taxes IncomeTaxExpenseBenefit $10.27K USD 1 Quarter
Provision for income taxes IncomeTaxExpenseBenefit $10.27K USD 1 Quarter
Provision for income taxes IncomeTaxExpenseBenefit $11.52K USD 2 Qtrs
Provision for income taxes IncomeTaxExpenseBenefit $11.52K USD 2 Qtrs
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-40.36K USD 2 Qtrs
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-40.36K USD 2 Qtrs
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-22.00K USD 1 Quarter
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-22.00K USD 1 Quarter
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-12.91K USD 1 Quarter
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-12.91K USD 1 Quarter
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-84.99K USD 2 Qtrs
Net loss attributable to non-controlling interests NetIncomeLossAttributableToNoncontrollingInterest $-84.99K USD 2 Qtrs
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-9.65M USD 2 Qtrs
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-9.65M USD 2 Qtrs
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-6.06M USD 2 Qtrs
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-6.06M USD 2 Qtrs
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-4.39M USD 1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-4.39M USD 1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-3.58M USD 1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders NetIncomeLoss $-3.58M USD 1 Quarter
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $27.36K USD 1 Quarter
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $27.36K USD 1 Quarter
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-6.14K USD 2 Qtrs
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-6.14K USD 2 Qtrs
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-1.67K USD 1 Quarter
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-1.67K USD 1 Quarter
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-17.69K USD 2 Qtrs
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-17.69K USD 2 Qtrs
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-6.14K USD 2 Qtrs
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-6.14K USD 2 Qtrs
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-17.69K USD 2 Qtrs
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-17.69K USD 2 Qtrs
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $27.36K USD 1 Quarter
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $27.36K USD 1 Quarter
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-1.67K USD 1 Quarter
Total other comprehensive loss OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-1.67K USD 1 Quarter
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-6.06M USD 2 Qtrs
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-6.06M USD 2 Qtrs
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-4.37M USD 1 Quarter
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-4.37M USD 1 Quarter
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-3.58M USD 1 Quarter
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-3.58M USD 1 Quarter
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-9.67M USD 2 Qtrs
Comprehensive loss ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-9.67M USD 2 Qtrs
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 1 Quarter
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 1 Quarter
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 2 Qtrs
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 2 Qtrs
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 1 Quarter
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 1 Quarter
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 2 Qtrs
Less: comprehensive loss attributable to non-controlling interests OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest - USD 2 Qtrs
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-9.67M USD 2 Qtrs
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-9.67M USD 2 Qtrs
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-4.37M USD 1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-4.37M USD 1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-6.06M USD 2 Qtrs
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-6.06M USD 2 Qtrs
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-3.58M USD 1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders ComprehensiveIncomeNetOfTax $-3.58M USD 1 Quarter
Loss per common share - basic EarningsPerShareBasic $-0.36 USD 2 Qtrs
Loss per common share - basic EarningsPerShareBasic $-0.36 USD 2 Qtrs
Loss per common share - basic EarningsPerShareBasic $-0.24 USD 1 Quarter
Loss per common share - basic EarningsPerShareBasic $-0.24 USD 1 Quarter
Loss per common share - basic EarningsPerShareBasic $-0.15 USD 1 Quarter
Loss per common share - basic EarningsPerShareBasic $-0.15 USD 1 Quarter
Loss per common share - basic EarningsPerShareBasic $-0.42 USD 2 Qtrs
Loss per common share - basic EarningsPerShareBasic $-0.42 USD 2 Qtrs
Loss per common share - diluted EarningsPerShareDiluted $-0.15 USD 1 Quarter
Loss per common share - diluted EarningsPerShareDiluted $-0.15 USD 1 Quarter
Loss per common share - diluted EarningsPerShareDiluted $-0.36 USD 2 Qtrs
Loss per common share - diluted EarningsPerShareDiluted $-0.36 USD 2 Qtrs
Loss per common share - diluted EarningsPerShareDiluted $-0.42 USD 2 Qtrs
Loss per common share - diluted EarningsPerShareDiluted $-0.42 USD 2 Qtrs
Loss per common share - diluted EarningsPerShareDiluted $-0.24 USD 1 Quarter
Loss per common share - diluted EarningsPerShareDiluted $-0.24 USD 1 Quarter
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 14.47M shares 2 Qtrs
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 14.47M shares 2 Qtrs
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 15.04M shares 1 Quarter
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 15.04M shares 1 Quarter
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 27.07M shares 2 Qtrs
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 27.07M shares 2 Qtrs
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 28.79M shares 1 Quarter
Weighted average shares outstanding - basic WeightedAverageNumberOfSharesOutstandingBasic 28.79M shares 1 Quarter
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 15.04M shares 1 Quarter
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 15.04M shares 1 Quarter
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 14.47M shares 2 Qtrs
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 14.47M shares 2 Qtrs
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 28.79M shares 1 Quarter
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 28.79M shares 1 Quarter
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 27.07M shares 2 Qtrs
Weighted average shares outstanding - diluted WeightedAverageNumberOfDilutedSharesOutstanding 27.07M shares 2 Qtrs
Cash Flow Statement 122 line items
Line Item Tag Value Unit Period
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Stock-based compensation ShareBasedCompensation $1.58M USD 2 Qtrs
Stock-based compensation ShareBasedCompensation $1.58M USD 2 Qtrs
Stock-based compensation ShareBasedCompensation $777.58K USD 2 Qtrs
Stock-based compensation ShareBasedCompensation $777.58K USD 2 Qtrs
Depreciation Depreciation $1.01K USD 2 Qtrs
Depreciation Depreciation $1.01K USD 2 Qtrs
Depreciation Depreciation $6.89K USD 2 Qtrs
Depreciation Depreciation $6.89K USD 2 Qtrs
Amortization of right of use asset FinanceLeaseRightOfUseAssetAmortization - USD 2 Qtrs
Amortization of right of use asset FinanceLeaseRightOfUseAssetAmortization - USD 2 Qtrs
Amortization of right of use asset FinanceLeaseRightOfUseAssetAmortization $41.26K USD 2 Qtrs
Amortization of right of use asset FinanceLeaseRightOfUseAssetAmortization $41.26K USD 2 Qtrs
Tax receivable IncreaseDecreaseInIncomeTaxesReceivable $815.29K USD 2 Qtrs
Tax receivable IncreaseDecreaseInIncomeTaxesReceivable $815.29K USD 2 Qtrs
Tax receivable IncreaseDecreaseInIncomeTaxesReceivable $47.24K USD 2 Qtrs
Tax receivable IncreaseDecreaseInIncomeTaxesReceivable $47.24K USD 2 Qtrs
Prepaid expenses and other current assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets $278.48K USD 2 Qtrs
Prepaid expenses and other current assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets $278.48K USD 2 Qtrs
Prepaid expenses and other current assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets $1.37M USD 2 Qtrs
Prepaid expenses and other current assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets $1.37M USD 2 Qtrs
Other assets IncreaseDecreaseInOtherCurrentAssets - USD 2 Qtrs
Other assets IncreaseDecreaseInOtherCurrentAssets - USD 2 Qtrs
Other assets IncreaseDecreaseInOtherCurrentAssets $20.42K USD 2 Qtrs
Other assets IncreaseDecreaseInOtherCurrentAssets $20.42K USD 2 Qtrs
Accounts payable and accrued expenses IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities $1.13M USD 2 Qtrs
Accounts payable and accrued expenses IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities $1.13M USD 2 Qtrs
Accounts payable and accrued expenses IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities $119.78K USD 2 Qtrs
Accounts payable and accrued expenses IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities $119.78K USD 2 Qtrs
Operating lease liability IncreaseDecreaseInOperatingLeaseLiability - USD 2 Qtrs
Operating lease liability IncreaseDecreaseInOperatingLeaseLiability - USD 2 Qtrs
Operating lease liability IncreaseDecreaseInOperatingLeaseLiability $19.24K USD 2 Qtrs
Operating lease liability IncreaseDecreaseInOperatingLeaseLiability $19.24K USD 2 Qtrs
Net cash used in operating activities NetCashProvidedByUsedInOperatingActivities $-5.61M USD 2 Qtrs
Net cash used in operating activities NetCashProvidedByUsedInOperatingActivities $-5.61M USD 2 Qtrs
Net cash used in operating activities NetCashProvidedByUsedInOperatingActivities $-9.08M USD 2 Qtrs
Net cash used in operating activities NetCashProvidedByUsedInOperatingActivities $-9.08M USD 2 Qtrs
Purchase of property and equipment PaymentsToAcquirePropertyPlantAndEquipment $398.99K USD 2 Qtrs
Purchase of property and equipment PaymentsToAcquirePropertyPlantAndEquipment $398.99K USD 2 Qtrs
Purchase of property and equipment PaymentsToAcquirePropertyPlantAndEquipment - USD 2 Qtrs
Purchase of property and equipment PaymentsToAcquirePropertyPlantAndEquipment - USD 2 Qtrs
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities $-398.99K USD 2 Qtrs
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities $-398.99K USD 2 Qtrs
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities - USD 2 Qtrs
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities - USD 2 Qtrs
Payments of deferred offering costs PaymentOfFinancingAndStockIssuanceCosts $175.82K USD 2 Qtrs
Payments of deferred offering costs PaymentOfFinancingAndStockIssuanceCosts $175.82K USD 2 Qtrs
Payments of deferred offering costs PaymentOfFinancingAndStockIssuanceCosts - USD 2 Qtrs
Payments of deferred offering costs PaymentOfFinancingAndStockIssuanceCosts - USD 2 Qtrs
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $13.57M USD Point-in-time
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $13.57M USD Point-in-time
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $15.95M USD 2 Qtrs
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $15.95M USD 2 Qtrs
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $4.81M USD 2 Qtrs
Proceeds from sale of common stock, net of offering costs ProceedsFromIssuanceOfCommonStock $4.81M USD 2 Qtrs
Proceeds from exercise of stock options ProceedsFromIssuanceInitialPublicOffering - USD 2 Qtrs
Proceeds from exercise of stock options ProceedsFromIssuanceInitialPublicOffering - USD 2 Qtrs
Proceeds from exercise of stock options ProceedsFromIssuanceInitialPublicOffering $2.49K USD 2 Qtrs
Proceeds from exercise of stock options ProceedsFromIssuanceInitialPublicOffering $2.49K USD 2 Qtrs
Funds received for subsidiary private offering ProceedsFromIssuanceOfPrivatePlacement - USD 2 Qtrs
Funds received for subsidiary private offering ProceedsFromIssuanceOfPrivatePlacement - USD 2 Qtrs
Funds received for subsidiary private offering ProceedsFromIssuanceOfPrivatePlacement $175.00K USD 2 Qtrs
Funds received for subsidiary private offering ProceedsFromIssuanceOfPrivatePlacement $175.00K USD 2 Qtrs
Net cash provided by financing activities NetCashProvidedByUsedInFinancingActivities $15.95M USD 2 Qtrs
Net cash provided by financing activities NetCashProvidedByUsedInFinancingActivities $15.95M USD 2 Qtrs
Net cash provided by financing activities NetCashProvidedByUsedInFinancingActivities $4.81M USD 2 Qtrs
Net cash provided by financing activities NetCashProvidedByUsedInFinancingActivities $4.81M USD 2 Qtrs
Effect of foreign currency on cash EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $-1.46K USD 2 Qtrs
Effect of foreign currency on cash EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $-1.46K USD 2 Qtrs
Effect of foreign currency on cash EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $13.57K USD 2 Qtrs
Effect of foreign currency on cash EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $13.57K USD 2 Qtrs
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $6.47M USD 2 Qtrs
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $6.47M USD 2 Qtrs
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $-783.19K USD 2 Qtrs
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $-783.19K USD 2 Qtrs
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $17.51M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $17.51M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $12.65M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $12.65M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $13.44M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $13.44M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $23.98M USD Point-in-time
Cash and cash equivalents beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $23.98M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $17.51M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $17.51M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $12.65M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $12.65M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $13.44M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $13.44M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $23.98M USD Point-in-time
Cash and cash equivalents end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $23.98M USD Point-in-time
Income taxes paid IncomeTaxesPaidNet $11.52K USD 2 Qtrs
Income taxes paid IncomeTaxesPaidNet $11.52K USD 2 Qtrs
Income taxes paid IncomeTaxesPaidNet $19.11K USD 2 Qtrs
Income taxes paid IncomeTaxesPaidNet $19.11K USD 2 Qtrs
Establishment of right of use asset and liabilities RightOfUseAssetAndLiabilities $1.07M USD 2 Qtrs
Establishment of right of use asset and liabilities RightOfUseAssetAndLiabilities $1.07M USD 2 Qtrs
Establishment of right of use asset and liabilities RightOfUseAssetAndLiabilities - USD 2 Qtrs
Establishment of right of use asset and liabilities RightOfUseAssetAndLiabilities - USD 2 Qtrs
Deferred offering costs charged against proceeds from sale of common stock DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock $87.23K USD 2 Qtrs
Deferred offering costs charged against proceeds from sale of common stock DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock $87.23K USD 2 Qtrs
Deferred offering costs charged against proceeds from sale of common stock DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock $125.82K USD 2 Qtrs
Deferred offering costs charged against proceeds from sale of common stock DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock $125.82K USD 2 Qtrs
Shares issued in subsidiary absorption SharesIssuedInSubsidiaryAbsorption - USD 2 Qtrs
Shares issued in subsidiary absorption SharesIssuedInSubsidiaryAbsorption - USD 2 Qtrs
Shares issued in subsidiary absorption SharesIssuedInSubsidiaryAbsorption $99.00 USD 2 Qtrs
Shares issued in subsidiary absorption SharesIssuedInSubsidiaryAbsorption $99.00 USD 2 Qtrs
Nexcella shares issued for funds previously received SharesIssuedForFundsPreviouslyReceived $475.00K USD 2 Qtrs
Nexcella shares issued for funds previously received SharesIssuedForFundsPreviouslyReceived $475.00K USD 2 Qtrs
Nexcella shares issued for funds previously received SharesIssuedForFundsPreviouslyReceived - USD 2 Qtrs
Nexcella shares issued for funds previously received SharesIssuedForFundsPreviouslyReceived - USD 2 Qtrs
Stockholders Equity 80 line items
Line Item Tag Value Unit Period
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $101.32K USD 1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $101.32K USD 1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $4.58M USD 1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $4.58M USD 1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $338.50K USD 1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts $338.50K USD 1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs StockIssuedDuringPeriodValueNewIssues $15.52M USD 1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs StockIssuedDuringPeriodValueNewIssues $15.52M USD 1 Quarter
Shares issued for exercise of stock options StockIssuedDuringPeriodValueStockOptionsExercised $2.49K USD 1 Quarter
Shares issued for exercise of stock options StockIssuedDuringPeriodValueStockOptionsExercised $2.49K USD 1 Quarter
Shares issued for exercise of stock options, shares StockIssuedDuringPeriodSharesStockOptionsExercised 1,251.00 shares 2 Qtrs
Shares issued for exercise of stock options, shares StockIssuedDuringPeriodSharesStockOptionsExercised 1,251.00 shares 2 Qtrs
Shares issued for services StockIssuedDuringPeriodValueIssuedForServices $102.50K USD 1 Quarter
Shares issued for services StockIssuedDuringPeriodValueIssuedForServices $102.50K USD 1 Quarter
Shares issued for services StockIssuedDuringPeriodValueIssuedForServices $327.38K USD 1 Quarter
Shares issued for services StockIssuedDuringPeriodValueIssuedForServices $327.38K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $615.89K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $615.89K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $447.66K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $447.66K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $535.35K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $535.35K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $329.92K USD 1 Quarter
Stock-based compensation StockIssuedDuringPeriodValueShareBasedCompensation $329.92K USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Non-controlling interests in subsidiary NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance - USD 1 Quarter
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-2.50M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-4.41M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-5.33M USD 1 Quarter
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-6.10M USD 2 Qtrs
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-3.60M USD 1 Quarter
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Net loss ProfitLoss $-9.74M USD 2 Qtrs
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-1.67K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-1.67K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $27.36K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $27.36K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-45.05K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-45.05K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-4.47K USD 1 Quarter
Foreign currency translation adjustment OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $-4.47K USD 1 Quarter
Buyout of non-controlling interests in subsidiary BuyoutOfNoncontrollingInterestsInSubsidiary - USD 1 Quarter
Buyout of non-controlling interests in subsidiary BuyoutOfNoncontrollingInterestsInSubsidiary - USD 1 Quarter
Nexcella shares issued for cash proceeds StockIssuedDuringPeriodValueOther $650.00K USD 1 Quarter
Nexcella shares issued for cash proceeds StockIssuedDuringPeriodValueOther $650.00K USD 1 Quarter
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $16.20M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $23.89M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.16M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $11.74M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $27.63M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $13.17M USD Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.

NEWS
Loading news...
TRENDING
Loading...